Annual Drug Patent Expirations for REZDIFFRA Rezdiffra is a drug marketed by Madrigal and is included in one NDA. It is available from one supplier. There are four patents protecting…
Source
Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are fourteen…
Source
Annual Drug Patent Expirations for AYVAKIT Ayvakit is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are four patents…
Source
Brivaracetam is the generic ingredient in two branded drugs marketed by Ucb Inc, Aurobindo Pharma Ltd, Lupin Ltd, Sunshine, and Zydus Pharms and, and is included in seven NDAs. There…
Source
New tentative approval for Annora Pharma drug brivaracetam Read Post »
Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It is available from one supplier. There are eight patents protecting…
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five…
Source
New tentative approval for MSN drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most patents in Ireland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source
Which pharmaceutical companies have the most drug patents in Ireland? Read Post »
In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions (PTEs) to extend regulatory timeframes for medical devices in the…
Source
Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices Read Post »
Annual Drug Patent Expirations for VYONDYS+53 Vyondys 53 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
Source
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are seventy patents…
Source
Get new actionable insights and updates from BiotechBlog
